EICHOR
● Completed
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Condition: Metastatic Hormone-sensitive Prostate Cancer · Sponsor: ECOG-ACRIN Cancer Research Group
About this study
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen ablation therapy may stop the adrenal glands from making androgens. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether androgen-ablation therapy is more effective with or without docetaxel in treating metastatic prostate cancer. PURPOSE: This randomized phase III trial is studying androgen-ablation therapy and chemotherapy to see how well they work compared to androgen-ablation therapy alone in treating patients with metastatic prostate cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (343)
| Providence Cancer Center | Anchorage, Alaska, United States | — |
| Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital | Fairbanks, Alaska, United States | — |
| Mayo Clinic Hospital | Phoenix, Arizona, United States | — |
| Mayo Clinic Scottsdale | Scottsdale, Arizona, United States | — |
| Hembree Mercy Cancer Center at St. Edward Mercy Medical Center | Fort Smith, Arkansas, United States | — |
| Arkansas Cancer Research Center at University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Alta Bates Summit Comprehensive Cancer Center | Berkeley, California, United States | — |
| Peninsula Medical Center | Burlingame, California, United States | — |
| California Cancer Care, Incorporated - Greenbrae | Greenbrae, California, United States | — |
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles, California, United States | — |
| Tibotec Therapeutics - Division of Ortho Biotech Products, LP | Marysville, California, United States | — |
| Mather Veteran Affairs Medical Center | Mather, California, United States | — |
+ 331 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00309985